Imualfa 1.6 Mg Injection

Description

About Imualfa 1.6 mg Injection

Imualfa 1.6 mg Injection contains thymosin alpha 1, supplied as a single vial for subcutaneous injection, given as directed by a doctor.

How it works

Thymosin alpha 1 is a synthetic version of a peptide produced naturally by the thymus gland. It acts on the immune system rather than on a virus or tumour directly, helping T cells to mature and improving the body’s own immune response to infected or abnormal cells.

What it is used for

Thymosin alpha 1 is used as an adjunctive treatment in chronic hepatitis B and chronic hepatitis C, and as an immune-modulating adjunct in some patients with reduced immune function. It is used alongside standard treatment, not instead of it, and its place in therapy is decided by the treating specialist.

Important safety information

It is generally well tolerated, with discomfort or redness at the injection site being the most frequently reported effect. Tell your doctor if you have an autoimmune condition, have had an organ transplant, or are taking medicines that suppress the immune system, as an immune-stimulating medicine may not be appropriate. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding.

This is a prescription-only medicine. It should be used only under the supervision of a qualified healthcare professional, who will decide whether it is suitable for you and at what dose.